Free Cash Flow

Plus Therapeutics Inc

Plus Therapeutics Inc (PSTV)

$2.55
-0.24 (-8.60%)
Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
Revenue 12.207.6011.6611.386.416.657.006.756.516.286.055.84
Revenue (%)
Operating Cash Flow -34.56-30.33-20.47-19.53-18.13-11.98-5.91-15.20-14.66-14.14-13.63-13.15
Operating Cash Flow (%)
Capital Expenditure -0.52-1.02-0.62-0.07-1.50-0.13-0.07-0.48-0.46-0.45-0.43-0.42
Capital Expenditure (%)
Free Cash Flow -35.08-31.35-21.09-19.60-19.62-12.11-5.97-15.68-15.12-14.59-14.07-13.57

FCF Unlevered from cash flow statement